For decades, healthcare innovation moved largely from the inside out.
Hospitals, insurers, pharmaceutical companies and regulators determined how care was delivered, while patients largely navigated the options available to them. Innovation was driven by institutions, and consumers were expected to adapt.
That model is changing.
Across the United States, millions of patients are increasingly taking healthcare decisions into their own hands, seeking out services that are more accessible, personalized and responsive than traditional care pathways often provide. In doing so, they are helping create what many have begun to call a shadow healthcare system: a growing ecosystem of digital platforms, virtual clinics, diagnostic tools and consumer health services that exist alongside traditional healthcare infrastructure.
As an investor focused on healthcare innovation, I believe this represents one of the most important structural shifts occurring across healthcare today.
The rise of healthcare's consumer layer
Patients are no longer willing to wait for the healthcare system to evolve around them.
Years of fragmented care experiences, long wait times, opaque pricing, and limited access to specialized services have driven consumers to seek alternatives. Technology has made those alternatives increasingly accessible.
Today, patients can access fertility care, nutritional counseling, hormonal health services, mental health support, chronic disease management and specialist consultations through platforms designed around convenience, accessibility and continuous engagement.
What began as a niche trend has become a meaningful force within healthcare.
Telehealth adoption remains dramatically higher than pre-pandemic levels, and a growing percentage of outpatient care is expected to shift into home-based, virtual, or digitally enabled settings over the coming decade.
Importantly, this shadow healthcare system is not replacing traditional healthcare.
Instead, it is becoming a powerful source of innovation and patient engagement that increasingly influences how the broader healthcare system evolves.
The most successful companies are not building outside the system. They are creating new front doors into it.
The evolution of the direct-to-consumer model
For years, many investors believed direct-to-consumer healthcare would fundamentally disrupt traditional healthcare.
Most were wrong.
Healthcare is ultimately a multi-stakeholder market involving patients, providers, employers, health systems and insurers. Pure direct-to-consumer healthcare businesses have historically struggled to achieve venture-scale outcomes because healthcare spending and decision-making rarely reside with consumers alone.
But while the original thesis proved flawed, something more interesting emerged.
Direct-to-consumer turned out not to be the destination. It became the wedge.
The most successful healthcare companies now use consumer engagement to validate demand, build trust, improve care delivery and generate outcomes data before expanding into employer, payer and provider channels.
Companies such as Kindbody and Nourish illustrate this evolution. Rather than waiting for reimbursement contracts or health system partnerships before launching, they built direct relationships with consumers first. As those relationships deepened and outcomes became measurable, employers, insurers and healthcare organizations increasingly became partners rather than gatekeepers.
Consumer adoption became the mechanism through which broader healthcare integration occurred. Historically, healthcare companies sought institutional adoption first and patient adoption second.
Today, many of the most successful companies begin with patients and use that engagement to earn adoption across the rest of the healthcare ecosystem.
The winners are not bypassing the healthcare system.
They are using consumer demand to help reshape it.
The most important healthcare consumer is a woman
One of the most overlooked realities in healthcare is that women make approximately 80% of healthcare decisions for their families.
They are often the primary healthcare decision-makers not only for themselves, but also for children, partners and aging parents.
Yet many of the healthcare categories that matter most to women have historically received limited attention from both healthcare systems and investors. Fertility, menopause, hormonal health, caregiving, maternal health and many chronic conditions affecting women have remained underserved despite representing enormous economic and societal impact.
The rise of consumer healthcare is helping address this imbalance.
By building directly for patients rather than institutions, founders are identifying needs that traditional healthcare models have often overlooked. In many cases, women are driving adoption, engagement and ultimately the growth of entirely new healthcare categories.
The result is not simply better consumer experiences. It is the creation of new healthcare infrastructure around some of the largest unmet needs in medicine.
The AI opportunity is bigger than most people realize
Artificial intelligence is often discussed through the lens of algorithms.
The more important story may be data.
For decades, healthcare datasets have been incomplete, fragmented and, in many cases, biased toward populations and conditions that have historically received the most attention from researchers and healthcare institutions.
Consumer healthcare companies are beginning to change that.
By building direct relationships with patients, they are generating entirely new categories of longitudinal health data that previously did not exist at scale.
Consider the work being done by Evvy, which is building one of the largest datasets focused on the vaginal microbiome. For decades, this area of women's health remained dramatically understudied despite its connection to fertility, pregnancy outcomes, infections and broader health conditions. Through direct consumer engagement and novel biomarker collection, companies like Evvy are helping create datasets that simply did not exist before.
This is happening across healthcare.
The organizations best positioned to benefit from AI may not ultimately be those with the most sophisticated algorithms. They may be the ones that have spent years building trusted consumer relationships and accumulating proprietary datasets that competitors cannot easily replicate.
In an AI-driven future, data is increasingly becoming strategic infrastructure.
The next frontier
Despite significant innovation over the past decade, some of healthcare's largest categories remain underserved.
Chronic pain and musculoskeletal care continue to represent one of the largest cost burdens within healthcare. Autoimmune disease, metabolic health, hormonal health, caregiving support and longevity-related care remain areas where patient demand often outpaces available solutions.
These are precisely the categories where consumer healthcare models can thrive.
The opportunity is not necessarily to reinvent medicine. It is to create better access, stronger engagement, more personalized experiences and more continuous support around existing clinical care.
Patients are becoming the organizing force in healthcare
For decades, healthcare innovation flowed from institutions to patients.
Increasingly, it is flowing in the opposite direction.
Patients are discovering new pathways to care, validating new models of delivery and creating entirely new datasets that will shape the next generation of healthcare innovation.
The most successful companies will not be those that choose between consumers and the healthcare system. They will be the ones that use consumer trust as a bridge to connect patients, providers, employers, payers and technology in ways that were previously impossible.
The shadow healthcare system is no longer operating in the shadows. It is helping shape the future of healthcare itself.
Rachel Springate is a founding partner of Muse Capital.